Endo International Ordinary Shares traded at $0.47 this Thursday June 30th, decreasing $0.06 or 10.89 percent since the previous trading session. Looking back, over the last four weeks, Endo International lost 11.75 percent. Over the last 12 months, its price fell by 90.20 percent. Looking ahead, we forecast Endo International Ordinary Shares to be priced at 0.35 by the end of this quarter and at 0.31 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
0.47
Daily Change
-10.89%
Yearly
-90.20%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Takeda 3,818.00 19.00 0.50% 2.14%
AbbVie 153.16 -0.98 -0.64% 34.05%
Aerie Pharmaceuticals 7.50 -0.30 -3.85% -53.76%
Amarin 1.49 -0.33 -18.13% -66.59%
ANI Pharmaceuticals 29.67 1.81 6.50% -17.56%
Bristol-Myers Squibb 77.00 -1.28 -1.64% 15.69%
Coherus Biosciences 7.24 -0.16 -2.16% -49.19%
Endo International 0.47 -0.06 -10.89% -90.20%
Hikma Pharmaceutical 1,617.50 -28.00 -1.70% -36.32%
Heron Therapeutics 2.79 -0.38 -11.99% -81.40%
Horizon Pharma 79.76 -2.74 -3.32% -17.42%
Jazz Pharmaceuticals 156.01 -0.35 -0.22% -13.89%
Lannett 0.58 -0.01 -1.66% -87.11%
Ligand Pharmaceuticals 89.22 0.74 0.84% -34.36%
Eli Lilly 324.23 1.23 0.38% 40.28%
Merck & Co 91.17 -1.34 -1.45% 16.90%
Novartis 80.85 -0.34 -0.42% -4.23%
Phibro Animal Health 19.13 -0.06 -0.31% -36.25%
Pacira 58.30 -0.33 -0.56% -2.80%
Patterson Companies 30.30 -0.61 -1.97% -1.53%
Pfizer 52.43 1.49 2.93% 32.53%
Perrigo 40.57 -0.40 -0.98% -13.14%
Revance Therapeutics 13.82 -0.41 -2.88% -54.79%
Supernus Pharmaceuticals 28.92 0.42 1.47% -7.87%
Teva Pharmaceutical Industries Ltd 2,670.00 -83.00 -3.01% -18.10%
Xeris Pharmaceuticals Inc 1.54 0.06 4.05% -63.07%
Zoetis 171.89 -2.03 -1.17% -9.19%

Indexes Price Day Year
US500 3779 -33.45 -0.88% -12.53%
USND 11029 -149.16 -1.33% -24.06%
US400 2269 -21.75 -0.95% -16.49%

Endo International
Endo International plc is a generics and specialty branded pharmaceutical company. The Company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals and International Pharmaceuticals. It has a portfolio of branded pharmaceuticals offered by its U.S. Branded Pharmaceuticals segment that includes brand names, such as Lidoderm, OPANA ER, Voltaren Gel, Percocet, Fortesta Gel, Testim, TESTOPEL, Aveed, Supprelin LA and XIAFLEX. Its non-branded U.S. Generic Pharmaceuticals portfolio consists of products, such as tablets, capsules, powders, injectables, liquids, nasal sprays, ophthalmics and patches. The Company's generics portfolio has a range of dosage forms and delivery systems. The International Pharmaceuticals segment includes various specialty pharmaceutical products for the Canadian, Latin American and world markets.